TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Not Specified
AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

AOP Health US announced expanded distribution of Rapiblyk™ (landiolol), an FDA-approved ultra-short-acting beta-blocker for treating rapid heart rates in critical care settings. The drug is now available through four major pharmaceutical wholesalers: Cardinal, Cencora Specialty Distribution, McKesson Corporation, and Morris & Dickson, enhancing accessibility for hospitals and health systems nationwide.

Insights
SHOP   neutral

Mentioned in context of beta-testing Managed Markets flow without detailed performance information


CAH   neutral

Cardinal is mentioned as one of four distribution partners for Rapiblyk, representing routine business expansion but without specific financial impact or strategic significance disclosed in the article.